» Articles » PMID: 20682521

Plasma Urate and Parkinson's Disease in Women

Overview
Journal Am J Epidemiol
Specialty Public Health
Date 2010 Aug 5
PMID 20682521
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

Plasma urate has been consistently associated with a lower risk of Parkinson's disease in men, but it is less clear if this relation exists in women. Between 1990 and 2004, the authors conducted a nested case-control study among participants of the female-only Nurses' Health Study. In controls (n = 504), plasma urate was positively associated with age, body mass index, alcohol consumption, hypertension, and use of diuretics and was inversely associated with physical activity and postmenopausal hormone use, as expected. Mean urate levels were 5.04 mg/dL for cases (n = 101) and 4.86 mg/dL for controls (P = 0.17). The age-, smoking-, and caffeine-adjusted rate ratio comparing women in the highest (≥5.8 mg/dL) with those in the lowest (<4.0 mg/dL) quartile was 1.33 (95% confidence interval: 0.69, 2.57; P(trend) = 0.4). Further adjustment for body mass index, physical activity, history of hypertension, and postmenopausal hormone use did not change the results. Unlike in men, these findings do not support the hypothesis that urate is strongly associated with lower rates of Parkinson's disease among women.

Citing Articles

Association between high uric acid and the risk of Parkinson's disease: A meta-analysis.

Zhang J, Zeng L, Bu L, Liao H, Wang M, Xiong Y Medicine (Baltimore). 2024; 103(30):e38947.

PMID: 39058857 PMC: 11272381. DOI: 10.1097/MD.0000000000038947.


Update: Protective and risk factors for Parkinson disease.

Grotewold N, Albin R Parkinsonism Relat Disord. 2024; 125:107026.

PMID: 38879999 PMC: 11846500. DOI: 10.1016/j.parkreldis.2024.107026.


Parkinson's disease updates: Addressing the pathophysiology, risk factors, genetics, diagnosis, along with the medical and surgical treatment.

Prajjwal P, Flores Sanga H, Acharya K, Tango T, John J, Rodriguez R Ann Med Surg (Lond). 2023; 85(10):4887-4902.

PMID: 37811009 PMC: 10553032. DOI: 10.1097/MS9.0000000000001142.


Glutathione-Mediated Neuroprotective Effect of Purine Derivatives.

Matsumura N, Aoyama K Int J Mol Sci. 2023; 24(17).

PMID: 37685879 PMC: 10487553. DOI: 10.3390/ijms241713067.


Parkinson's Disease Case Ascertainment in the Sister Study: A Cohort for Environmental Health Research.

Cao Z, Song S, Huang X, Li C, Luo Z, DAloisio A J Parkinsons Dis. 2023; 13(5):729-742.

PMID: 37334620 PMC: 10473078. DOI: 10.3233/JPD-230053.


References
1.
Duan W, Ladenheim B, Cutler R, Kruman I, Cadet J, Mattson M . Dietary folate deficiency and elevated homocysteine levels endanger dopaminergic neurons in models of Parkinson's disease. J Neurochem. 2002; 80(1):101-10. DOI: 10.1046/j.0022-3042.2001.00676.x. View

2.
Chen H, OReilly E, McCullough M, Rodriguez C, Schwarzschild M, Calle E . Consumption of dairy products and risk of Parkinson's disease. Am J Epidemiol. 2007; 165(9):998-1006. PMC: 2232901. DOI: 10.1093/aje/kwk089. View

3.
Ascherio A, LeWitt P, Xu K, Eberly S, Watts A, Matson W . Urate as a predictor of the rate of clinical decline in Parkinson disease. Arch Neurol. 2009; 66(12):1460-8. PMC: 2795011. DOI: 10.1001/archneurol.2009.247. View

4.
Chen H, Mosley T, Alonso A, Huang X . Plasma urate and Parkinson's disease in the Atherosclerosis Risk in Communities (ARIC) study. Am J Epidemiol. 2009; 169(9):1064-9. PMC: 2727240. DOI: 10.1093/aje/kwp033. View

5.
de Lau L, Koudstaal P, Hofman A, Breteler M . Serum uric acid levels and the risk of Parkinson disease. Ann Neurol. 2005; 58(5):797-800. DOI: 10.1002/ana.20663. View